Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 4,881 | 7,956 | 4,412 | 2,845 | 1,683 |
| Cost of Goods | 146 | 34 | 164 | 120 | 105 |
| Gross Profit | 4,735 | 7,922 | 4,248 | 2,725 | 1,578 |
| Operating Expenses | 34,116 | 30,795 | 32,953 | 27,905 | 24,030 |
| Operating Income | -29,235 | -22,839 | -28,541 | -25,060 | -22,347 |
| Interest Expense | 1,888 | 2,722 | 2,821 | 2,822 | 2,875 |
| Other Income | 654 | 56,098 | 970 | 1,394 | 1,662 |
| Pre-tax Income | -30,469 | 30,537 | -30,392 | -26,488 | -23,560 |
| Net Income Continuous | -30,469 | 30,537 | -30,392 | -26,488 | -23,560 |
| Net Income | $-30,469 | $30,537 | $-30,392 | $-26,488 | $-23,560 |
| EPS Basic Total Ops | -11,037.79 | 10,677.86 | -11,157.77 | -9,238.15 | -8,038.39 |
| EPS Basic Continuous Ops | -11,039.28 | 10,672.79 | -11,149.09 | -9,182.36 | -8,074.25 |
| EPS Diluted Total Ops | -11,037.79 | 10,677.86 | -11,157.77 | -9,238.15 | -8,038.39 |
| EPS Diluted Continuous Ops | -11,039.28 | 10,672.79 | -11,149.09 | -9,182.36 | -8,074.25 |
| EBITDA(a) | $-27,205 | $-19,083 | $-25,222 | $-21,628 | $-18,614 |